Greater China
China's XVC raises $274m for third US dollar fund
Beijing-based venture capital firm XVC has raised USD 274m for its third US dollar-denominated vehicle. It brings overall assets under management to USD 1.2bn.
China's METiS Pharmaceuticals raises $150m
METiS Pharmaceuticals, a Hangzhou-based drug formulation company has raised USD 150m through two funding rounds led by PICC Capital and China Life PE.
Deal focus: Nio Capital gets real with Nreal
Nio Capital invested in Nreal with a view to seeing the Chinese start-up’s augmented reality glasses feature in smart cockpits in next-generation cars. The company is now pushing for scale
Taiwan's Gogoro trades up on NASDAQ following SPAC merger
Gogoro, a Taiwan-based start-up that has developed a battery-swapping technology for scooters, gained 10% on its NASDAQ trading debut following the completion of a merger with a special purpose acquisition company (SPAC) backed by the former CIO of Morgan...
China cybersecurity provider ThreatBook raises $47m
Beijing-based cybersecurity solutions provider ThreatBook has raised CNY 300m (USD 47m) in an extended Series E round led by CDH Investments, featuring existing investor Star Road Ventures.
China MSME financier raises $70m
Micro Connect, a China-based provider of financing to micro, small and medium-sized enterprises (MSMEs), has raised USD 70m in Series B funding.
Alibaba leads Series C extension for China AR start-up Nreal
Nreal, a Chinese manufacturer of augmented reality (AR) glasses that resemble normal sunglasses, has raised an extended Series C of USD 60m led by Alibaba Group.
CDH, Huaxing lead $120m Series B for China's InnoRNA
CDH Investments and Huaxing Healthcare Fund have led a USD 120m Series B for InnoRNA, a China-based mRNA drug developer. Existing investors CPE and Fangyuan Capital re-upped.
China EV maker Eezi raises $78m
Shenzhen-based electronic vehicle (EV) manufacturer Eezi has raised a CNY 500m (USD 78m) pre-A round led by China Merchants Venture.
Deal focus: Jade Invest rides pest control M&A boom
Having offered a blueprint for pest control consolidation globally in Anticimex, EQT wants to repeat the trick in China with Guardian Hygiene Service. It meant a 3.3x return for previous owner Jade Invest
Investment becomes Tencent's main profit driver in 2021
Investment accounted for the bulk of Tencent Holdings' annual profit for the first time in 2021 as the Chinese technology giant saw earnings from its core business contract in the second half of the year.
China's JD Property closes $800m Series B
Warburg Pincus and Hillhouse Investment have re-upped in JD Property, the infrastructure property asset management arm of Chinese e-commerce giant JD.com, as part of a USD 800m Series B round.
PAG files for Hong Kong IPO
PAG, which has seen its assets under management (AUM) across private equity, credit, and real assets grow 6x to more than USD 50bn in the past decade, has become the first large-cap Asian manager to file for an IPO.
CBC strikes China's first royalty-based biomedicine deal
R-Bridge Fund, a credit vehicle established by healthcare-focused private equity firm CBC Group, has completed what it claims is the first royalty-backed investment in China’s biomedicine space.
China enterprise AR specialist Rokid raises $160m
Rokid, a China-based company specialising in augmented reality (AR) technology applications, has raised USD 160m in Series C funding across two tranches.
China AI start-up Aibee joins unicorn club
China-based artificial intelligence start-up Aibee has achieved a valuation of more than USD 1bn on closing a new funding round led by smartphone brand Xiaomi and featuring China Merchants Capital.
EQT buys China pest control business
EQT Private Equity Asia has acquired majority stake in Guardian Hygiene Service, China’s largest domestic pest control company, for an undisclosed sum. It facilitates a full exit for Jade Invest.
Primavera SPAC to merge with Fosun-owned fashion platform
A special purpose acquisition company (SPAC) with ties to China-based private equity firm Primavera Capital Group has agreed to merge with global luxury fashion platform Lanvin Group at a pro forma enterprise valuation of USD 1.5bn.
Eight Roads launches $350m China tech fund
Eight Roads Ventures has raised a China fund with a corpus of USD 350m which will make venture and early growth investments across enterprise, financial, and consumer technologies
Deal focus: Medilink chases global ADC opportunity
The Medilink Therapeutics team spun out from Kelun-Biotech to develop antibody drug conjugates capable of competing with the world’s best. Its USD 70m Series B will support the pursuit of this goal
China's Nio Capital closes Fund II on $400m
Nio Capital, a China-based investment firm established by the founder of domestic electric vehicle (EV) manufacturer Nio, has raised USD 400m for its second US-dollar denominated fund.
Trustar buys China condiments supplier
Trustar Capital, formerly known as CITIC Capital Partners, has acquired China-based food condiments supplier Beijing Salion Foods for an undisclosed sum.
AppWorks targets $360m for Fund IV, launches Web3 arm
Taiwan-based VC firm and accelerator AppWorks has established a dedicated Web3 arm and plans to launch its fourth flagship fund with a target of USD 360m in the second quarter of 2022.
PE-owned Belle Fashion files for Hong Kong IPO
China’s largest women’s footwear retailer Belle Fashion, which is backed by Hillhouse Capital and CDH Investments, has filed for a Hong Kong IPO with a reported target of USD 1bn.